Galen E.B. Wright
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
-
- Genetic Neurodegenerative Diseases
Papers in
- Genetics 16
- Genetic Associations and Epidemiology 10
- Genomics and Rare Diseases 4
-
- Mitochondrial Function and Pathology 4
- Co-authors
- Britt I. Drögemöller (30 shared papers)Louise Warnich (15 shared papers)Colin J.D. Ross (18 shared papers)Michael R. Hayden (10 shared papers)Bruce Carleton (12 shared papers)Dana Niehaus (9 shared papers)Jennifer A. Collins (6 shared papers)Liezl Koen (5 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (6 papers)Pharmacogenomics (5 papers)npj Genomic Medicine (2 papers)Pharmacogenetics and Genomics (2 papers)Neuron (2 papers)
- Partner nations
- CanadaSouth AfricaUnited States
In The Last Decade
Galen E.B. Wright
52 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 103
- Pharmacology 404
- Cellular and Molecular Neuroscience 285
- Sensory Systems 52
- Genetics 276
- Neurology 114
Countries citing papers authored by Galen E.B. Wright
This map shows the geographic impact of Galen E.B. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galen E.B. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galen E.B. Wright more than expected).
Fields of papers citing papers by Galen E.B. Wright
This network shows the impact of papers produced by Galen E.B. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galen E.B. Wright. The network helps show where Galen E.B. Wright may publish in the future.
Co-authors
The 25 scholars most cited alongside Galen E.B. Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 135 | |
| 2 | 2016 | 70 | |
| 3 | 2016 | 67 | |
| 4 | 2011 | 57 | |
| 5 | 2018 | 57 | |
| 6 | 2018 | 56 | |
| 7 | 2020 | 53 | |
| 8 | 2013 | 50 | |
| 9 | 2010 | 48 | |
| 10 | 2021 | 46 | |
| 11 | 2013 | 43 | |
| 12 | 2010 | 43 | |
| 13 | 2020 | 42 | |
| 14 | 2013 | 41 | |
| 15 | 2020 | 36 | |
| 16 | 2021 | 35 | |
| 17 | 2013 | 31 | |
| 18 | Bupropion in the long-term treatment of cyclic mood disorders: mood stabilizing effects. | 1985 | 31 |
| 19 | 2018 | 30 | |
| 20 | 2014 | 25 |
About Galen E.B. Wright
Galen E.B. Wright is a scholar working on Genetics, Molecular Biology, Pharmacology, Cellular and Molecular Neuroscience and Oncology, having authored 52 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (13 papers), Genetic Associations and Epidemiology (10 papers), Genetic Neurodegenerative Diseases (9 papers), Schizophrenia research and treatment (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Genomics and Rare Diseases (4 papers), Mitochondrial Function and Pathology (4 papers) and Cholesterol and Lipid Metabolism (2 papers). The work is most often cited by research in Pharmacology (404 citations), Cellular and Molecular Neuroscience (285 citations), Sensory Systems (52 citations), Genetics (276 citations) and Neurology (114 citations). Galen E.B. Wright has collaborated with scholars based in Canada, South Africa and United States. Frequent co-authors include Britt I. Drögemöller, Louise Warnich, Colin J.D. Ross, Michael R. Hayden, Bruce Carleton, Dana Niehaus, Jennifer A. Collins, Liezl Koen, Nicki Tiffin and Scott Hazelhurst. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Pharmacogenomics, npj Genomic Medicine, Pharmacogenetics and Genomics and Neuron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.